{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T18:58:42Z","timestamp":1768071522769,"version":"3.49.0"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T00:00:00Z","timestamp":1583712000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1038\/s41372-020-0644-y","type":"journal-article","created":{"date-parts":[[2020,3,9]],"date-time":"2020-03-09T13:02:48Z","timestamp":1583758968000},"page":"1025-1030","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Maternal antidepressant use during pregnancy and neonatal hypoglycemia: prospective cohort study"],"prefix":"10.1038","volume":"40","author":[{"given":"Jyotsna","family":"Shah","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla","family":"Sarmiento","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prakesh S.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,3,9]]},"reference":[{"key":"644_CR1","doi-asserted-by":"publisher","first-page":"2372","DOI":"10.1001\/jama.293.19.2372","volume":"293","author":"EL Moses-Kolko","year":"2005","unstructured":"Moses-Kolko EL, Bogen D, Perel J, Bregar A, Uhl K, Levin B, et al. Neonatal signs after late in utero exposure to serotonin reuptake inhibitors: literature review and implications for clinical applications. JAMA. 2005;293:2372\u201383.","journal-title":"JAMA"},{"key":"644_CR2","doi-asserted-by":"publisher","first-page":"e111327","DOI":"10.1371\/journal.pone.0111327","volume":"9","author":"L Forsberg","year":"2014","unstructured":"Forsberg L, Naver L, Gustafsson LL, Wide K. Neonatal adaptation in infants prenatally exposed to antidepressants\u2013clinical monitoring using Neonatal Abstinence Score. PloS ONE. 2014;9:e111327.","journal-title":"PloS ONE"},{"key":"644_CR3","unstructured":"van Driel JJ, Wennink JH, Heres MH, Honig A. Intrauterine exposure to SSRIs: no reason for routine hypoglycaemia screening. Ned Tijdschr Geneeskd. 2010;54:A339."},{"key":"644_CR4","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1001\/archpsyc.60.7.720","volume":"60","author":"K Laine","year":"2003","unstructured":"Laine K, Heikkinen T, Ekblad U, Kero P. Effects of exposure to selective serotonin reuptake inhibitors during pregnancy on serotonergic symptoms in newborns and cord blood monoamine and prolactin concentrations. Arch Gen Psychiatry. 2003;60:720\u20136.","journal-title":"Arch Gen Psychiatry"},{"key":"644_CR5","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.bpobgyn.2013.09.001","volume":"28","author":"GE Hanley","year":"2014","unstructured":"Hanley GE, Oberlander TF. The effect of perinatal exposures on the infant: antidepressants and depression. Best Pr Res Clin Obstet Gynaecol. 2014;28:37\u201348.","journal-title":"Best Pr Res Clin Obstet Gynaecol"},{"key":"644_CR6","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1136\/archdischild-2012-302569","volume":"98","author":"JP Boardman","year":"2013","unstructured":"Boardman JP, Wusthoff CJ, Cowan FM. Hypoglycaemia and neonatal brain injury. Arch Dis Child Educ Pr Ed. 2013;98:2\u20136.","journal-title":"Arch Dis Child Educ Pr Ed"},{"key":"644_CR7","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1001\/archpedi.158.4.312","volume":"158","author":"B Kallen","year":"2004","unstructured":"Kallen B. Neonate characteristics after maternal use of antidepressants in late pregnancy. Arch Pediatr Adolesc Med. 2004;158:312\u20136.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"644_CR8","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1542\/peds.2006-2133","volume":"119","author":"E Ferreira","year":"2007","unstructured":"Ferreira E, Carceller AM, Agogue C, Martin BZ, St-Andre M, Francoeur D, et al. Effects of selective serotonin reuptake inhibitors and venlafaxine during pregnancy in term and preterm neonates. Pediatrics. 2007;119:52\u20139.","journal-title":"Pediatrics"},{"key":"644_CR9","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1001\/archpedi.156.11.1129","volume":"156","author":"AM Costei","year":"2002","unstructured":"Costei AM, Kozer E, Ho T, Ito S, Koren G. Perinatal outcome following third trimester exposure to paroxetine. Arch Pediatr Adolesc Med. 2002;156:1129\u201332.","journal-title":"Arch Pediatr Adolesc Med"},{"key":"644_CR10","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1067\/mpd.2003.139","volume":"142","author":"RC Casper","year":"2003","unstructured":"Casper RC, Fleisher BE, Lee-Ancajas JC, Gilles A, Gaylor E, DeBattista A, et al. Follow-up of children of depressed mothers exposed or not exposed to antidepressant drugs during pregnancy. J Pediatr. 2003;142:402\u20138.","journal-title":"J Pediatr"},{"key":"644_CR11","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1017\/S0033291709992194","volume":"40","author":"M Reis","year":"2010","unstructured":"Reis M, Kallen B. Delivery outcome after maternal use of antidepressant drugs in pregnancy: an update using Swedish data. Psychol Med. 2010;40:1723\u201333.","journal-title":"Psychol Med"},{"key":"644_CR12","doi-asserted-by":"publisher","first-page":"e20160181","DOI":"10.1542\/peds.2016-0181","volume":"138","author":"U N\u00f6rby","year":"2016","unstructured":"N\u00f6rby U, Forsberg L, Wide K, Sj\u00f6rs G, Winbladh B, K\u00e4ll\u00e9n K. Neonatal morbidity after maternal use of antidepressant drugs during pregnancy. Pediatrics. 2016;138:e20160181.","journal-title":"Pediatrics"},{"key":"644_CR13","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/1471-0528.14144","volume":"123","author":"AC Eke","year":"2016","unstructured":"Eke AC, Saccone G, Berghella V. Selective serotonin reuptake inhibitor (SSRI) use during pregnancy and risk of preterm birth: a systematic review and meta-analysis. BJOG. 2016;123:1900\u20137.","journal-title":"BJOG"},{"key":"644_CR14","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1016\/j.jad.2011.07.022","volume":"135","author":"A Roca","year":"2011","unstructured":"Roca A, Garcia-Esteve L, Imaz ML, Torres A, Hern\u00e1ndez S, Botet F, et al. Obstetrical and neonatal outcomes after prenatal exposure to selective serotonin reuptake inhibitors: the relevance of dose. J Affect Disord. 2011;135:208\u201315.","journal-title":"J Affect Disord"},{"key":"644_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s00213-011-2270-z","volume":"217","author":"RC Casper","year":"2011","unstructured":"Casper RC, Gilles AA, Fleisher BE, Baran J, Enns G, Lazzeroni LC. Length of prenatal exposure to selective serotonin reuptake inhibitor (SSRI) antidepressants: effects on neonatal adaptation and psychomotor development. Psychopharmacology. 2011;217:211\u20139.","journal-title":"Psychopharmacology"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41372-020-0644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-020-0644-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41372-020-0644-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:31:02Z","timestamp":1684618262000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-020-0644-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,9]]},"references-count":15,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["644"],"URL":"https:\/\/doi.org\/10.1038\/s41372-020-0644-y","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,9]]},"assertion":[{"value":"27 October 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2020","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2020","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2020","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}